Page 66 - ARNM-2-3

Advances in Radiotherapy
& Nuclear Medicine NCRT for T3N0M0 ESCC

neoadjuvant chemoradiotherapy in clinical T2N0M0 survival in esophageal cancer patients undergoing
esophageal cancer: A population-based cohort study. Eur J neoadjuvant chemotherapy followed by surgery. Ann Surg.
Surg Oncol. 2018;44(5):620-625. 2022;275(6):1121-1129.
doi: 10.1016/j.ejso.2018.02.005 doi: 10.1097/SLA.0000000000004238
10. Mariette C, Dahan L, Mornex F, et al. Surgery alone 19. Lightdale CJ, Kulkarni KG. Role of endoscopic
versus chemoradiotherapy followed by surgery for stage I ultrasonography in the staging and follow-up of esophageal
and II esophageal cancer: Final analysis of randomized cancer. J Clin Oncol. 2005;23(20):4483-4489.
controlled phase III trial FFCD 9901. J Clin Oncol. doi: 10.1200/JCO.2005.20.644
2014;32(23):2416-2422.
20. Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA,
doi: 10.1200/jco.2013.53.6532
Antillon MR. Staging accuracy of esophageal cancer by
11. Robb WB, Dahan L, Mornex F, et al. Impact of neoadjuvant endoscopic ultrasound: A meta-analysis and systematic
chemoradiation on lymph node status in esophageal cancer. review. World J Gastroenterol. 2008;14(10):1479-1490.
Ann Surg. 2015;261(5):902-908.
doi: 10.3748/wjg.14.1479
doi: 10.1097/sla.0000000000000991
21. Lee G, Hoseok H, Kim SJ, et al. Clinical implication of
12. Dijksterhuis WP, Hulshoff JB, Van Dullemen HM, et al. PET/MR imaging in preoperative esophageal cancer staging:
Reliability of clinical nodal status regarding response to Comparison with PET/CT, endoscopic ultrasonography,
neoadjuvant chemoradiotherapy compared with surgery and CT. J Nucl Med. 2014;55(8):1242-1247.
alone and prognosis in esophageal cancer patients. Acta doi: 10.2967/jnumed.114.138974
Oncol. 2019;58(11):1640-1647.
22. Gabriel E, Attwood K, Du W, et al. Association between
doi: 10.1080/0284186X.2019.1648865
clinically staged node-negative esophageal adenocarcinoma
13. Wang Q, Peng L, Li T, et al. Postoperative chemotherapy for and overall survival benefit from neoadjuvant
thoracic pathological T3N0M0 esophageal squamous cell chemoradiation. JAMA Surg. 2016;151(3):234-245.
carcinoma. Ann Surg Oncol. 2020;27(5):1488-1495.
doi: 10.1001/jamasurg.2015.4068
doi: 10.1245/s10434-019-08112-1
23. Gao HJ, Wei YC, Gong L, et al. Neoadjuvant
14. Yang J, Zhang W, Xiao Z, et al. The impact of postoperative chemoradiotherapy plus surgery versus surgery alone
conformal radiotherapy after radical surgery on survival and for clinical node-negative esophageal carcinoma. Thorac
recurrence in pathologic T3N0M0 esophageal carcinoma: Cancer. 2020;11(9):2618-2629.
A propensity score-matched analysis. J Thorac Oncol. doi: 10.1111/1759-7714.13586
2017;12(7):1143-1151.
24. Van Hagen P, Hulshof MC, Van Lanschot JJ, et al. Preoperative
doi: 10.1016/j.jtho.2017.03.024
chemoradiotherapy for esophageal or junctional cancer.
15. Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, N Engl J Med. 2012;366(22):2074-2084.
Blackstone EH. Cancer of the esophagus and esophagogastric
junction-Major changes in the American joint committee doi: 10.1056/NEJMoa1112088
on cancer eighth edition cancer staging manual. CA Cancer 25. Speicher PJ, Wang X, Englum BR, et al. Induction
J Clin. 2017;67(4):304-317. chemoradiation therapy prior to esophagectomy is
associated with superior long-term survival for esophageal
doi: 10.3322/caac.21399
cancer. Dis Esophagus. 2015;28(8):788-796.
16. Davies AR, Myoteri D, Zylstra J, et al. Lymph node
regression and survival following neoadjuvant doi: 10.1111/dote.12285
chemotherapy in oesophageal adenocarcinoma. Br J Surg. 26. Li T, Fu X, Xiao L, et al. The long-term impact of tumor
2018;105(12):1639-1649. burden in pT3N0M0 esophageal squamous cell carcinoma.
Medicine. 2019;98(42):e17637.
doi: 10.1002/bjs.10900
doi: 10.1097/md.0000000000017637
17. Hsu PK, Yeh YC, Chien LI, Huang CS, Hsu HS.
Clinicopathological significance of pathologic complete 27. Situ D., Wei W, Lin P, et al. Do tumor grade and
lymph node regression after neoadjuvant chemoradiotherapy location affect survival in esophageal squamous cell
in esophageal squamous cell carcinoma. Ann Surg Oncol. carcinoma? Survival analysis of 302 cases of pT3N0M0
2021;28(4):2048-2058. esophageal squamous cell carcinoma. Ann Surg Oncol.
2012;20(2):580-585.
doi: 10.1245/s10434-020-09363-z
doi: 10.1245/s10434-012-2656-0
18. Hagi T, Makino T, Yamasaki M, et al. Pathological
regression of lymph nodes better predicts long-term 28. Ho HJ, Chen HS, Hung WH, et al. Survival impact of total

Volume 2 Issue 3 (2024) 11 doi: 10.36922/arnm.3821